Deep TMS for Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a non-invasive brain stimulation technique called deep repetitive TMS on a brain region linked to memory. It aims to see if this treatment can improve symptoms in people with mild-to-moderate Alzheimer's disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 100 years old.
- You have been diagnosed with Alzheimer's dementia (or Alzheimer's clinical syndrome).
- You have a caregiver or study partner who can come with you to all visits.
- You have a surrogate decision-maker who can come to the consent visit (this can be the same person).
- Your MMSE score (a memory test) is between 18 and 26.
- You are not on certain medications that affect the brain, like strong allergy meds or seizure drugs, unless the study doctor approves.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a brain stimulation treatment called rTMS can improve symptoms in people with Alzheimer’s disease. It mainly looks at people with mild to moderate dementia and checks whether results differ based on how the treatment is applied.
This trial tests whether transcranial magnetic stimulation (TMS), a noninvasive brain treatment, can help people with early Alzheimer's or mild cognitive impairment. It aims to see if the treatment is safe and effective for slowing memory decline.
This study tests a type of brain stimulation called Deep TMS to help reduce depression and improve or stabilize memory-related symptoms in older adults with Alzheimer’s disease. It’s mainly for people whose depression did not improve or could not be tolerated with antidepressant medicine.
This study tests whether a non-invasive brain stimulation treatment called TMS (transcranial magnetic stimulation) can help people with early Alzheimer's disease or related memory problems. It's a safe, gentle way to stimulate brain cells using magnetic pulses.
This trial uses a non-invasive brain stimulation technique (TMS) to target the cerebellum in people with Alzheimer's disease. It aims to see if this treatment can improve symptoms and cognitive function.
This study tests whether a noninvasive magnetic brain stimulation treatment can slow down cognitive decline in people with early Alzheimer's disease. You'll receive daily sessions over several weeks, and the goal is to see if it helps preserve memory and thinking skills.
Hear when a new Dementia Alzheimer Type trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.